Resultados y vida financieraSalud - Farma - Biotecnología
Inside Information / Other news releases
12/11/2026 07:30
AMFPublicación inmediata
Paris, France – November 12, 2026, 7:30 am CET – Aliko Scientific (Ikonisys SA – Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, announces the upcoming launch of CYTOfast Auto, a next-generation automated Liquid-Based Cytology (LBC)…
Aliko Scientific launches CYTOfast Auto at MEDICA 2026, expanding into high-volume screening markets
- Expanding Aliko Scientific's reach into high-volume laboratories and large-scale screening programs, within a global cytology market projected to reach USD 38.2 billion by 2030
- New fully automated liquid-based cytology platform combining Hospitex's proprietary technology with advanced robotics
- Designed to improve laboratory efficiency, streamline workflows and ensure standardized, high-quality sample preparation
- Supporting the expansion of the Group's installed base and the development of recurring revenues from reagents, consumables and services
Paris, France – November 12, 2026, 7:30 am CET – Aliko Scientific (Ikonisys SA – Euronext Growth Paris: ALIKO), an international life sciences Group dedicated to integrated oncology diagnostics, announces the upcoming launch of CYTOfast Auto, a next-generation automated Liquid-Based Cytology (LBC) system developed by its wholly owned subsidiary Hospitex International.
The new platform will be unveiled at MEDICA 2026, taking place in Düsseldorf, Germany, from November 16 to 19, marking an important milestone in Aliko Scientific's strategy to expand its presence in high-volume hospital laboratories, public healthcare institutions and large-scale screening programs.
Francesco Trisolini, CEO of Aliko Scientific, commented: "CYTOfast Auto represents a significant step forward in our strategy to transform Aliko Scientific into an increasingly integrated and scalable diagnostics group. By combining Hospitex's proven technology with advanced robotics, we are opening the door to new market segments, particularly public hospitals and large-scale screening programs.
We believe this innovation will strengthen our competitive international positioning while supporting the expansion of our installed base and the development of recurring revenues. It is another important step in translating our technological expertise into sustainable long-term growth."
Combining Proven Technology with Advanced Automation
CYTOfast Auto builds on the established CYTOfast System, retaining its core technological advantages while introducing fully automated sample preparation.
At its heart is Hospitex's proprietary Nephelometric Smart Technology (NST), which analyzes cellular concentration and automatically determines the optimal sample volume to produce homogeneous, high-quality monolayer slides. The integration of NST with advanced robotics introduces several innovations, including full walk-away processing, continuous sample loading, priority processing of urgent samples and automated sample-to-slide traceability. These features are designed to improve laboratory efficiency, reduce manual intervention and ensure standardized, reproducible sample preparation across multiple cytological applications.